Search research articles
Contact Us
Filters
Showing results (41-50 of 302) with videos related to
Page
of 31
Sort By:
Diabetologia
|
April 20, 2021
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Amalia Gastaldelli, Norbert Stefan, Hans-Ulrich Häring
The Lancet. Diabetes & Endocrinology
|
September 4, 2018
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans-Ulrich Häring, Kenneth Cusi
JAMA
|
February 12, 2004
Regulation of synovial adipocytokines
Norbert Stefan, Hans-Ulrich Häring, Michael Stumvoll
JAMA
|
November 24, 2005
Insulin resistance and congestive heart failure
Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring
The New England Journal of Medicine
|
July 25, 2009
The importance of brown adipose tissue
Norbert Stefan, Christina Pfannenberg, Hans-Ulrich Häring
Journal of the American College of Cardiology
|
April 29, 2014
Mechanisms explaining the relationship between metabolically healthy obesity and cardiovascular risk
Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring
Diabetes Care
|
November 22, 2014
Comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014;37:1296-1303
Norbert Stefan, Andreas Peter, Hans-Ulrich Häring
JAMA
|
November 20, 2008
Association of fetuin-A level and diabetes risk
Norbert Stefan, Hans-Ulrich Häring, Matthias B Schulze
Metabolism: Clinical and Experimental
|
August 25, 2024
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
European Journal of Radiology
|
February 7, 2024
Comparison of the accuracy of commercial two-point and multi-echo Dixon MRI for quantification of fat in liver, paravertebral muscles, and vertebral bone marrow
Tobias Haueise, Fritz Schick, Norbert Stefan, et al.
Page
of 31
Search research articles
Search
Showing results (41-50 of 302) with videos related to
Sort By:
Page
of 31
Diabetologia
|
April 20, 2021
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Amalia Gastaldelli, Norbert Stefan, Hans-Ulrich Häring
The Lancet. Diabetes & Endocrinology
|
September 4, 2018
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans-Ulrich Häring, Kenneth Cusi
JAMA
|
February 12, 2004
Regulation of synovial adipocytokines
Norbert Stefan, Hans-Ulrich Häring, Michael Stumvoll
JAMA
|
November 24, 2005
Insulin resistance and congestive heart failure
Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring
The New England Journal of Medicine
|
July 25, 2009
The importance of brown adipose tissue
Norbert Stefan, Christina Pfannenberg, Hans-Ulrich Häring
Journal of the American College of Cardiology
|
April 29, 2014
Mechanisms explaining the relationship between metabolically healthy obesity and cardiovascular risk
Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring
Diabetes Care
|
November 22, 2014
Comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014;37:1296-1303
Norbert Stefan, Andreas Peter, Hans-Ulrich Häring
JAMA
|
November 20, 2008
Association of fetuin-A level and diabetes risk
Norbert Stefan, Hans-Ulrich Häring, Matthias B Schulze
Metabolism: Clinical and Experimental
|
August 25, 2024
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
European Journal of Radiology
|
February 7, 2024
Comparison of the accuracy of commercial two-point and multi-echo Dixon MRI for quantification of fat in liver, paravertebral muscles, and vertebral bone marrow
Tobias Haueise, Fritz Schick, Norbert Stefan, et al.
Page
of 31